Biolase, Inc. BIOLQ
0.00
0.00
NaN
as of 23 Sep
- Market cap
- $2.3M
- P/E
- 0.0×
Follow BIOLQ
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.63 | 0.66 | 0.44 | 0.34 | 1.12 | 1.47 | 0.10 | 0.03 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(26.89) | (7.28) | (5.71) | (2.75) | (18.93) | (18.53) | (0.88) | (0.62) |
P/B ratio |
3.83 | 1.06 | 1.83 | 34.09 | 2.58 | 2.29 | 1.00 | 0.00 |
Price to Tangible BV |
4.42 | 1.18 | 2.49 | 0.00 | 3.65 | 2.59 | 2.50 | 0.00 |
EV/Sales |
1.52 | 0.48 | 0.57 | 0.53 | 1.06 | 1.06 | 0.30 | 0.18 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(7.43) | (1.22) | (1.84) | (1.59) | (1.89) | (2.47) | (0.54) | (0.63) |
EV/FCF |
(6.55) | (1.17) | (1.78) | (1.56) | (1.87) | (2.37) | (0.48) | (0.58) |
Quick Ratio |
1.05 | 1.65 | 1.22 | 0.58 | 1.87 | 2.49 | 0.56 | 0.61 |
Current Ratio |
1.89 | 2.70 | 2.09 | 1.05 | 3.13 | 3.57 | 1.63 | 1.26 |
Net Debt/EBITDA |
0.65 | 0.71 | (0.13) | (0.51) | 0.08 | 1.04 | (0.41) | (0.51) |
Debt/Assets |
0.38% | 0.00% | 28.13% | 42.29% | 40.20% | 25.34% | 36.12% | 40.02% |
Debt/Equity |
0.01 | 0.00 | 0.98 | 3.10 | 1.64 | 0.56 | 2.82 | 7.18 |
Asset Turnover |
1.23 | 1.11 | 1.13 | 1.07 | 0.63 | 0.81 | 1.04 | 1.34 |
Operating CF/Net income |
0.60 | 0.88 | 0.66 | 0.71 | 0.37 | 1.00 | 0.93 | 0.37 |
Capex/Depreciation |
(1.35) | (0.62) | (0.41) | (0.16) | (0.10) | (0.77) | (2.20) | (0.35) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (74.72%) | (81.17%) | (106.65%) | (311.44%) | (665.05%) | (95.22%) | (191.94%) | (1,620.81%) | |
| (41.70%) | (49.05%) | (52.80%) | (50.75%) | (93.88%) | (34.69%) | (61.73%) | (102.66%) | |
ROIC |
(71.66%) | (64.93%) | (96.20%) | (83.37%) | (134.04%) | (113.59%) | (109.22%) | (118.79%) |
Return on Tangible Assets |
(85.84%) | (79.04%) | (111.40%) | (733.87%) | (138.66%) | (45.67%) | (186.98%) | (350.76%) |
Average Days of Receivables |
68.93 | 78.75 | 87.88 | 84.59 | 49.01 | 39.47 | 43.99 | 40.71 |
Research and Development Expense of Revenue |
15.05% | 13.27% | 11.27% | 12.61% | 16.22% | 15.43% | 14.99% | 12.21% |
Selling, General and Administrative Expense of Revenue |
53.02% | 56.32% | 64.76% | 66.52% | 92.25% | 67.87% | 70.13% | 58.29% |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.08 | 0.09 | 0.07 | 0.05 | 0.08 | 0.08 |
Share Based Compensation of Revenue |
5.92% | 4.70% | 6.00% | 7.38% | 22.00% | 4.24% | 4.75% | 3.42% |
Graham Net Nets |
0.17 | 0.72 | 0.29 | (0.04) | 0.16 | 0.34 | (0.89) | (5.89) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.90 |
Earnings Yield |
(18.39%) | (55.54%) | (106.06%) | (142.93%) | (141.59%) | (29.40%) | (577.38%) | (2,961.82%) |
Free Cash Flow Yield |
(14.21%) | (61.85%) | (72.28%) | (100.80%) | (50.51%) | (30.28%) | (622.24%) | (1,082.66%) |
Revenue per Share |
10,573.47 | 7,953.56 | 5,628.66 | 4,064.41 | 929.80 | 664.20 | 702.35 | 38.47 |
Operating CF per Share |
(2,162.45) | (3,120.68) | (1,725.24) | (1,370.54) | (522.24) | (283.22) | (387.84) | (11.03) |
Capex per Share |
(288.57) | (126.61) | (63.66) | (22.26) | (3.92) | (11.98) | (54.01) | (0.88) |
Free Cash Flow per Share |
(2,451.02) | (3,247.29) | (1,788.90) | (1,392.80) | (526.16) | (295.20) | (441.86) | (11.91) |
Cash per Share |
1,872.45 | 2,016.27 | 1,019.02 | 656.02 | 729.63 | 511.44 | 60.59 | 5.14 |
Shareholders Equity per Share |
4,503.06 | 4,959.32 | 1,352.32 | 466.88 | 409.31 | 427.25 | 70.86 | 1.53 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4,503.06 | 4,959.32 | 1,352.32 | 466.88 | 409.31 | 427.25 | 70.86 | 1.53 |
Free Cash Flow |
(12.01) | (19.16) | (14.67) | (12.95) | (12.89) | (17.42) | (30.49) | (15.22) |
Working Capital |
15.97 | 22.68 | 17.34 | 1.24 | 23.89 | 35.51 | 11.15 | 5.20 |
Capital Expenditures |
(1.41) | (0.75) | (0.52) | (0.21) | (0.10) | (0.71) | (3.73) | (1.13) |
Net Current Asset Value |
14.11 | 22.33 | 5.88 | (0.49) | 4.11 | 19.28 | (4.34) | (8.28) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.02 | 0.08 | 0.02 |
Net Profit Margin |
(33.88%) | (44.39%) | (46.62%) | (47.24%) | (150.16%) | (42.63%) | (59.53%) | (76.52%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.23 | 0.33 | 0.64 | 1.10 | 1.27 | 0.86 | 0.40 | 0.58 |
Cash ROIC |
(48.01%) | (53.66%) | (53.24%) | (58.29%) | (30.58%) | (25.62%) | (135.77%) | (86.92%) |
Accounts Receivable Turnover |
5.53 | 4.71 | 4.35 | 3.80 | 3.85 | 10.74 | 9.62 | 8.68 |
Accounts Payable Turnover |
4.18 | 4.47 | 5.29 | 4.17 | 4.16 | 7.60 | 7.16 | 5.47 |
Inventory Turnover |
2.42 | 2.46 | 2.38 | 2.02 | 1.50 | 1.88 | 2.26 | 2.38 |
Average Days of Payables |
105.73 | 58.64 | 74.26 | 82.78 | 58.27 | 53.30 | 64.88 | 68.24 |
Days of Inventory on Hand |
156.69 | 141.16 | 152.79 | 170.69 | 245.22 | 208.27 | 178.11 | 128.64 |
Average Receivables |
9.37 | 9.95 | 10.62 | 9.94 | 5.91 | 3.65 | 5.04 | 5.66 |
Average Payables |
7.54 | 7.12 | 5.53 | 5.64 | 3.99 | 2.98 | 4.55 | 5.93 |
Average Inventory |
13.04 | 12.91 | 12.27 | 11.62 | 11.08 | 12.04 | 14.41 | 13.66 |
Average Assets |
42.10 | 42.46 | 40.75 | 35.18 | 36.44 | 48.15 | 46.74 | 36.64 |
Average Common Equity |
23.50 | 25.66 | 20.17 | 5.73 | 5.14 | 17.54 | 15.03 | 2.32 |
Columns are period end dates